Houston / Seville / New York City / Nashville / Chicago / /
Company
Cancer.Net / Health Services Research / /
Country
Norway / Canada / Finland / Austria / Spain / /
Facility
Barbara Bush Children’s Hospital / McMaster University / The University of Texas M.D. Anderson Cancer Center / Memorial Sloan-Kettering Cancer Center / Anna Children’s Cancer Research Institute / Maine Medical Center / Norwegian Radium Hospital / Massachusetts General Hospital / Memorial SloanKettering Cancer Center / Sarah Cannon Research Institute / Seville University Hospital / Helsinki University Central Hospital / National Cancer Institute of Canada Clinical Trials Group / University of Vienna / /
IndustryTerm
treatment of advanced or metastatic melanoma / Cancer Therapeutics / treatment for advanced melanoma / Treatment for Breast Cancer / treatment for patients with advanced or metastatic melanoma / treatment for ovarian cancer / treatment of cancer / cancer care / treatment for metastatic melanoma / care for breast and colon cancer / melanoma treatment / /
MedicalCondition
recurrent ovarian cancer / node-positive breast cancer / uterine cancer / ovarian cancer / DCIS / drive lung cancer / low-grade nonmelanoma skin cancer / advanced nonsquamous non-small cell lung cancer / advanced lung cancer / ductal carcinoma / neuroblastoma / Melanoma / injury / better controlled tumor / diarrhea / Breast Cancer / adenocarcinoma / leukemia / tumor / patient’s tumor / early-stage breast cancer / Gastrointestinal Stromal Tumor / node-positive disease / advanced cancers / cancer / Tumors / fallopian tube cancers / IV melanoma / successful melanoma / melanomas / Childhood Cancer / acute lymphoblastic leukemia / invasive breast cancer / chronic disease / fallopian tube cancer / High-quality cancer / rash / joint pain / metastatic melanoma / lower breast cancer / high-risk neuroblastoma / high-risk / nodenegative breast cancer / Advanced melanoma / nonmelanoma skin cancers / sleeplessness / blood clots / fatigue / Childhood ALL / pneumonitis / cancers / CANCER ADVANCES / person’s tumor / Lymphedema / disease / advanced cancer / Lung Cancer / noninvasive cancer / breast and colon cancer / person’s cancer / /
Division of Pediatric Hematology/Oncology / Seville University Hospital / American Society of Clinical Oncology / Barbara Bush Children’s Hospital / National Cancer Institute of Canada Clinical Trials Group / McMaster University in Ontario / Harvard Medical School / University of Texas M.D. Anderson Cancer Center / Sarah Cannon Research Institute / Norwegian Radium Hospital in Oslo / Maine Medical Center in Portland / Gynecologic Medical Oncology Service / Memorial SloanKettering Cancer Center / CONTENTS / Thoracic Oncology Service / Department of Investigational Cancer Therapeutics / St. Anna Children’s Cancer Research Institute in Vienna / Helsinki University Central Hospital in Helsinki / U.S. Food and Drug Administration / University of Vienna / Memorial Sloan-Kettering Cancer Center / Melanoma/Sarcoma Service / Massachusetts General Hospital in Boston / Gynecologic Medical Oncology Service at Memorial Sloan-Kettering Cancer Center / /
Person
Mark G. Kris / Paul E. Goss / Katherine Virgo / Apostalia-Maria Tsimberidou / George W. Sledge / Jedd Wolchok / Ruth Ladenstein / Paul Chapman / Heikki Joensuu / Eric C. Larsen / Gunnar Kristensen / Luis Paz-Ares / Carol Aghajanian / Jeffrey Infante / Timothy J. Whelan / /
Position
Consultant in the Department / President / lead study investigator / physician / Director of Immunotherapy Clinical Trials and Associate Attending Physician / Director of the Maine Children / Head / Chief / author / lead author / Professor of Pediatrics / Managing Director / Associate Professor / Professor of Oncology / lead study author and Professor of Medicine / Director of Drug Development / Chair / Director of the Maine Children’s Cancer Program / /
Cancer Advances NEWS FOR PATIENTS FROM THE 2011 ASCO ANNUAL MEETING P R O V I D I N G T H E L AT E S T I N F O R M AT I O N A B O U T C A N C E R R E S E A R C H PERSONALIZED MEDICINE